After opening its doors on October 2, 2012, and performing thousands of interventional pain and spine procedures, BPSI is pleased to be able to provide its patients and community a full range of care from conservative treatments to minimally invasive surgery; to best correct the underlying cause of painful conditions and now orthopedic and podiatric surgical conditions.
The goal of every medical approach at IPI and BPSI is the precise diagnosis of the underlying source of an individual's pain to alleviate discomfort and allow patients to return to their activities of daily living.
According to BPSI
president Greg Eiler, "The ultra-low false alarm rates and excellent real world operational up-time make the AIRGARD a perfect addition to our line-up of high performance detection equipment focused on saving human life."
BPSI is a physician-owned CRO that specializes in Phase I/IIa trials, including FIM trials, BE studies and bioanalysis, for international pharma and biopharma companies from the U.S., Canada, Australia and Europe.
"We are honored to partner with BPSI which has a great international reputation in the industry and with many regulatory agencies including US FDA, Health Canada and EMA.
I am excited to teach this course and getting to know each student on a professional level," said BPSI
Managing Director George Lora.